نتایج جستجو برای: hodgkin lymphomas

تعداد نتایج: 37471  

2016
Katelyn Hood Arpita Shah

Peripheral T-cell lymphomas (PTCLs) represent an uncommon heterogenous group of neoplasms that make up approximately 10% to 15% of non-Hodgkin lymphomas. PTCL, not otherwise specified (NOS) is the most common form, whose incidence in the United States has been increasing, possibly due to better diagnostic methods. PTCLs represent a rare and aggressive subgroup of NHLs that do not respond favora...

Journal: :South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1980
David J Good Randy D Gascoyne

This article provides an overview of the pathology and classification of non-Hodgkin lymphomas. Key histologic features are described for the common entities including both B-cell and T/NK-cell lineages. Additionally, details of the characteristic immunophenotypic findings, molecular genetic results, and common or clinically relevant cytogenetic alterations are described. Helpful tables are inc...

2009
Silke H. Raffegerst Gabriele Hoelzlwimmer Sandra Kunder Josef Mysliwietz Leticia Quintanilla-Martinez Dolores J. Schendel

A chimeric HLA-DR4-H2-E (DR4) homozygous transgenic mouse line spontaneously develops diverse hematological malignancies with high frequency (70%). The majority of malignancies were distributed equally between T and B cell neoplasms and included lymphoblastic T cell lymphoma (LTCL), lymphoblastic B cell lymphoma (LBCL), diffuse large B cell lymphoma (DLBCL), the histiocyte/T cell rich variant o...

Journal: :Egyptian Journal of Radiology and Nuclear Medicine 2021

Abstract Background Malignant lymphoma accounts for nearly 20% of all mediastinal neoplasms in adults and 50% children. Hodgkin’s disease is the most common primary lymphoma. In non-Hodgkin’s lymphoma, two forms are lymphoblastic diffuse large B-cell The aim this study to implement diffusion MRI algorithm diagnosis differentiating Hodgkin's from non-Hodgkin's assessment post therapeutic respons...

Journal: :Revista brasileira de hematologia e hemoterapia 2016
Marco Aurélio Salvino Jefferson Ruiz

The use of high-dose chemotherapy with autologous support of hematopoietic progenitor cells is an effective strategy to treat various hematologic neoplasms, such as non-Hodgkin lymphomas and multiple myeloma. Mobilized peripheral blood progenitor cells are the main source of support for autologous transplants, and collection of an adequate number of hematopoietic progenitor cells is a critical ...

2011
Thanyanan Reungwetwattana Sylvia Jaramillo Julian R. Molina

Peripheral T-cell lymphomas (PTCL) represent about 12%–15% of non-Hodgkin lymphomas and are characterized for being a molecularly heterogenous group of diseases. The optimal treatment for PTCLs remains to be defined as they are usually refractory to existing therapies and carry a poor prognosis. Pralatrexate (PDX), a rationally designed antifolate drug, was granted FDA approval as a single agen...

2017
Pilar Brito-Zerón Belchin Kostov Guadalupe Fraile Daniel Caravia-Durán Brenda Maure Francisco-Javier Rascón Mónica Zamora Arnau Casanovas Miguel Lopez-Dupla Mar Ripoll Blanca Pinilla Eva Fonseca Miriam Akasbi Gloria de la Red Miguel-Angel Duarte-Millán Patricia Fanlo Pablo Guisado-Vasco Roberto Pérez-Alvarez Antonio J. Chamorro César Morcillo Iratxe Jiménez-Heredia Isabel Sánchez-Berná Armando López-Guillermo Manuel Ramos-Casals M. Ramos-Casals P. Brito-Zerón S. Retamozo A. Bové H. Gheitasi I. Sánchez-Berná J. Gratacós G. Fraile J. Nava-Mateos B. Díaz-López D. Caravia-Duran A. García-Pérez A. Casanovas M. L. Morera-Morales T. E. Junco-Russeau F. J. Rascón L. Pallarés R. Pérez-Alvarez M. Perez-de-Lis M. Ripoll C. Moreno-delaSanta-García B. Pinilla C. López-GónzalezCobos M. Akasbi I. García-Sanchez B. Maure E. Fonseca M. A. Duarte-Millán J. Canora G de la Red N. Msabri A. J. Chamorro S. Rodríguez-Rodríguez I. Jiménez-Heredia M. A. López-Dupla J. A. Porras-Ledantes B. Villar-Navas J. Ramos-Rodriguez C. Morcillo M. Zamora P. Fanlo P. Guisado-Vasco B. Kostov A. Sisó-Almirall

BACKGROUND The purpose of this study is to characterize the risk of cancer in a large cohort of patients with primary Sjögren syndrome (SjS). METHODS We had analyzed the development of cancer in 1300 consecutive patients fulfilling the 2002 SjS classification criteria. The baseline clinical and immunological characteristics and systemic activity (ESSDAI scores) were assessed at diagnosis as p...

Journal: :Blood 2017
Justin Taylor Wenbin Xiao Omar Abdel-Wahab

Genomic analysis has greatly influenced the diagnosis and clinical management of patients affected by diverse forms of hematologic malignancies. Here, we review how genetic alterations define subclasses of patients with acute leukemias, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), non-Hodgkin lymphomas, and classical Hodgkin lymphoma. These include new subtypes of acute...

Journal: :Blood 2003
Bo Shi Hsin-Ling Hsu Andy M Evens Leo I Gordon Ronald B Gartenhaus

Our laboratory has recently discovered a novel candidate oncogene, MCT-1, amplified in human T-cell lymphoma and mapped to chromosome Xq22-24. This region is amplified in a subset of primary B-cell non-Hodgkin lymphoma (NHL), suggesting that increased copy number of a gene(s) located in this region confers a growth advantage to some primary human lymphomas. We examined a diverse panel of lympho...

Journal: :Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2012
Elena Vigliar Ciro Cipullo Paolo Todaro Giuseppe Giuffre Stefano Pepe

The association between some infections and non-Hodgkin lymphomas (NHL) is well known. Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human retrovirus to be discovered and has been found to be associated with adult T-cell leukemia/lymphoma (ATLL). Epstein-Barr virus (EBV) has consistently been linked to both endemic and sporadic Burkitt lymphoma (BL), as well as...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید